What is the value of the Global Clinical Trial Imaging Market?

The Global Clinical Trial Imaging Market was valued at US$ 1,067.3 Million in 2022 and it will reach USD 2,219.8 Million by 2032.

Why has the demand for clinical trial imaging increased?

The demand for clinical trial imaging has increased due to the emergence of new diseases like the COVID-19 pandemic and the need for developing drug treatments for these diseases.

Which application dominates the Clinical Trial Imaging Market?

NASH (Nonalcoholic Steatohepatitis) dominates the application segment of the global clinical trial imaging market.

Which end-user segment dominates the Clinical Trial Imaging Market?

Contract research organizations (CROs) dominate the market with the major revenue share of 45.8%.

What is the latest trend in the Clinical Trial Imaging Market?

The introduction of new protocols, such as the QIBA protocol, for better results is boosting the growth of the global clinical trial imaging market.

Which region holds the major revenue share in the Global Clinical Trial Imaging Market?

North America holds the major revenue share of 39.6% in the Global Clinical Trial Imaging Market.

Who are the key players in the Global Clinical Trial Imaging Market?

The key players in the Global Clinical Trial Imaging Market include IXICO plc, Navitas Life Sciences, Radiant Sage LLC, Resonance Health, Medpace, Biomedical Systems Corp, WCG Clinical, BioTelemetry, Keosys, Icon PLC, and others.

How are advanced medical devices impacting the accuracy of clinical trials?

Key players are focusing on the research and development of advanced medical devices to optimize the workload and improve the accuracy of clinical trials.

Global Clinical Trial Imaging Market By Service (Clinical Trial Design and Consultation Services, Operational Imaging Services, Reading and Analytical Services, System and Technology Support Services, and Project and Data Management), By Modality (Ultrasound, X-Ray, and Other Modalities), By Application, By End-Users, By Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends, and Forecast 2023 – 2032

Published date: September 2023
Report ID: 77788
Number of Pages: 278
Format:

- Keosys
- Navitas Life Sciences
- Radiant Sage LLC
- Resonance Health
- Medpace
- Biomedical Systems Corp
- WCG Clinical
- BioTelemetry
- IXICO plc
- Icon PLC
Settings

Related Reports

Our Clients

Inquiry Before Buying

Report ID 77788
Published Date September 2023
Rating
- ★★★★★
  
  ★★★★★
- (52)

Buy Now

Trusted by more than 17382 organizations globally

✖

Request a Sample Report

We'll get back to you as quickly as possible

	Single User $6,000 $3,999 USD / per unit save 24%	Multi User $8,000 $5,999 USD / per unit save 28%	Corporate User $10,000 $6,999 USD / per unit save 32%
e-Access
Report Library Access
Data Set (Excel)
Print
Company Profile Library Access
Interactive Dashboard
Free Custumization	No	up to 10 hrs work	up to 30 hrs work
Accessibility	1 User	2-5 User	Unlimited
Analyst Support	up to 20 hrs	up to 40 hrs	up to 50 hrs
Benefit	Up to 20% off on next purchase	Up to 25% off on next purchase	Up to 30% off on next purchase
	Buy Now ($ 3,999)	Buy Now ($ 5,999)	Buy Now ($ 6,999)